Status:
COMPLETED
i-PRF for Temporomandibular Joint Disorders
Lead Sponsor:
Eskisehir Osmangazi University
Conditions:
TMJ Disc Disorder
Treatment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will evaluate whether intra-articular injectable platelet-rich fibrin (i-PRF) is more effective than arthrocentesis alone in treating temporomandibular joint (TMJ) disorders. Patients will ...
Detailed Description
Temporomandibular joint (TMJ) disorders are a group of conditions that affect the jaw joint and surrounding muscles and ligaments. They can cause pain in the preauricular region, difficulty in opening...
Eligibility Criteria
Inclusion
- Patients ≥18 years old Diagnosed with temporomandibular joint disorder (TMD) based on clinical and radiological findings Presence of pain, restricted mouth opening, or joint sounds Voluntary participation and signed informed consent
Exclusion
- Systemic diseases affecting bone/joint healing (e.g., uncontrolled diabetes, rheumatoid arthritis, osteoporosis) Previous TMJ surgery or intra-articular injection Current pregnancy or breastfeeding Coagulopathy or anticoagulant therapy Allergy to hyaluronic acid (for control group) Inability to attend follow-up visits
Key Trial Info
Start Date :
September 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 16 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07188974
Start Date
September 2 2024
End Date
September 16 2025
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskisehir Osmangazi University
Eskişehir, Turkey (Türkiye), 26480